ENTITY
SYS6043
SYS6043
PulseAugur coverage of SYS6043 — every cluster mentioning SYS6043 across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
石药创新与阿斯利康达成 siRNA 药物合作，巨石生物获突破性疗法认定
Shijiazhuang Pharma Group (石药创新) subsidiary, Giant Biologics (巨石生物), has entered into a strategic collaboration with AstraZeneca to develop novel small interfering RNA (siRNA) drug candidates. AstraZeneca will pay an up…
-
Shijiazhuang Pharmaceutical's SYS6043 named breakthrough therapy for ovarian cancer
Shijiazhuang Pharmaceutical Group's subsidiary, Giant Biologics, has received a significant designation for its injectable drug SYS6043. The National Medical Products Administration's Center for Drug Evaluation has incl…